Log In
Copyright © 2009 American Chemical Society
April 6, 2009 Cover
Volume 87, Issue 14
COVER: Syringes full of the multiple sclerosis drugCopaxone are prepared by Teva Pharmaceutical, themedicine�s manufacturer.
Volume 87, Issue 14
MULTIPLE SCLEROSIS
A crop of small-molecule drugs in development could double the treatment options for people with multiple sclerosis in coming years
COVER: Syringes full of the multiple sclerosis drugCopaxone are prepared by Teva Pharmaceutical, themedicine�s manufacturer.
Credit: Teva Pharmaceutical
» Full Article
April 6, 2009 Issue
Volume 87, Issue 14
April 6, 2009 Issue, Vol. 87 | Iss. 14
A crop of small-molecule drugs in development could double the treatment options for people with multiple sclerosis in coming years
(pp. 10-15)
Features
Government & Policy
Rival bills in Congress differ in how long innovators can enjoy market exclusivity (pp. 23-25)
Science & Technology
Epigenetics, the molecular framework that controls genes’ expression, takes its cues from both nature and nurture (pp. 28-32)
News of the Week
Climate-Change Bill Introduced
Draft legislation launches House debate on how to cut greenhouse gas emissions
(p.6)BP Top Scientist Nominated For DOE Post
Koonin tapped to head Energy Department's Office of Science
(p.7)Low-Cost Iron For Fuel Cells
New synthetic route produces highly active non-precious-metal catalysts
(p.8)Priestley House May Be Shuttered
Pennsylvania state budget cuts could cease operation of ACS Historic Chemical Landmark
(p.9)Departments
Business
Polysilicon for solar panels proved to be strong performer for German company in 2008, but other units suffered
(pp. 18-19)
Oil companies use additive packages to help their fuels stand out from the crowd
(pp. 20-21)Concentrates
(pp. 16-17)
(pp. 16-17)- Dow NABS Rohm And Haas, Throws Salt Over Shoulder
- Solutia To Sell Nylon Business To SK Capital
- BASF Powers Up Lithium Batteries
- Materials Chemistry Center Set In U.K.
- Asahi Stops Making Polyester In Japan
- Three Plants Close In Europe
- Lyondell Wins Case On Appeal
- Chemical Makers Enable The Nano
- Genzyme Strikes Deal For Bayer Compounds
- Solvay Mulls Options For Drug Business
- Sutro Advances Cell-Free Proteins
- Evotec And Dyax Announce Job Cuts
- Lilly, Zydus Cadila Launch R&D Pact
- Business Roundup
ACS News
Derived from food products, these protein fragments could hold cancer, obesity, and other disorders at bay
(pp. 33-35)
Government & Policy
Rival bills in Congress differ in how long innovators can enjoy market exclusivity
(pp. 23-25)
Diplomats begin working out new global treaty to curb greenhouse gas emissions
Web ExclusiveBooks
National Academies book guides young researchers in responsible behavior
(p.7)
Science & Technology
A crop of small-molecule drugs in development could double the treatment options for people with multiple sclerosis in coming years
(pp. 10-15)
The founding generation of epigenetics-based drugs combine promise and peril
Web Exclusive
Epigenetic modifications alter chromatin landscape, turn genes on and off
Web Exclusive
Epigenetics, the molecular framework that controls genes’ expression, takes its cues from both nature and nurture
(pp. 28-32)Concentrates(pp. 26-27)
(pp. 26-27)- Mapping Out Lipids
- Improved Replicating Synthetic Membranes
- Dicarboxylic Acid Serves As Messenger For Plant Defense
- Inorganic Pores Maintain Flexible Attitude
- Blocking Brain Hormone Receptor Curbs Addiction . . .
- . . . As Could Thwarting An Addiction Gene
- Algal Neurotoxin Lingers In The Ocean
- Iron Complex Cleaves C–H and O–H Bonds
Career & Employment
As recessionary forces grip the globe, firms cut the fat from international staffing plans
(pp. 41-43)